Subclinical Atrial Fibrillation Home Monitoring in Hypertensive Patients

Recruiting Observational Study
Asymptomatic Atrial Fibrillation
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 and older
Sex
Any
Study type
Observational
Participants needed
499 (estimated)
Sponsor
Cardiovascular Research Center Rosario British Sanatorium · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Atrial fibrillation is a highly prevalent and incidental arrhythmia, often asymptomatic, and frequently detected incidentally or in association with a stroke. Subclinical atrial fibrillation increases cardioembolic risk, highlighting the need for timely diagnosis. New wireless devices capable of recording heart rhythm, combined with innovative artificial intelligence tools, could be useful in the…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 1\. Hypertensive patients of both sexes over 75 years of age. 2. Hypertensive patients between 65 and 75 years of age are associated with one of the following risk factors: 1. Obesity 2. Type 2 diabetes 3. Obstructive sleep apnea syndrome 4. Electrocardiogram showing …
Contacts

Daniel L Piskorz, MD

5493415416828

daniel.l.piskorz@gmail.com

CONTACT

Ricardo López Santi, MD

54 92215081467

lopezsan@live.com.ar

CONTACT